[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100370037":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":21,"centralContacts":26,"locations":34,"responsibleParty":54,"collaborators":7,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":60,"acronym":61,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":64,"maxAge":7,"enrollmentInfo":65,"targetDuration":7,"studyType":68,"phases":7,"briefSummary":69,"conditions":70,"keywords":72,"overallStatus":37,"whyStopped":7,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"University Hospital, Basel, Switzerland","OTHER",null,[9,12,15,18],{"type":6,"name":10,"description":11,"armGroupLabels":7,"otherNames":7},"data collection for demographic data","data collection for demographic data (age, gender, hospital admission and discharge date, length of stay, hospitalization prior to current hospital stay (acute care facilities, long-term healthcare centres, nursing homes), discharge destination, outcome, cause of death, travel history, previous exposure to antibiotics and proton pump Inhibitors)",{"type":6,"name":13,"description":14,"armGroupLabels":7,"otherNames":7},"data collection for clinical data","data collection for clinical data (comorbidities, Charlson Comorbidity Index, immunosuppressive treatment, date of diagnosis of CPB, days between hospital admission and diagnosis of CPB, type of consecutive infection, indwelling vascular hardware, urinary catheterization, surgical therapies)",{"type":6,"name":16,"description":17,"armGroupLabels":7,"otherNames":7},"data collection for treatment data","data collection for treatment data (antibiotic therapy, immunosuppressive therapy, concomitant medication)",{"type":6,"name":19,"description":20,"armGroupLabels":7,"otherNames":7},"data collection for microbiological data","data collection for microbiological data (species of CPB, type of sample, date of sample, history of colonization or infection with any antibiotic resistant pathogen)",[22],{"name":23,"affiliation":24,"role":25},"Sarah Tschudin Sutter, Prof. Dr. MD","University Hospital Basel, Division of Infectious Diseases and Hospital Epidemiology","PRINCIPAL_INVESTIGATOR",[27,31],{"name":23,"role":28,"phone":29,"phoneExt":7,"email":30},"CONTACT","+41 61 328 68 10","sarah.tschudin@usb.ch",{"name":32,"role":28,"phone":7,"phoneExt":7,"email":33},"Isabelle Vock, Dipl. med","isabelle.vock@usb.ch",[35],{"facility":36,"status":37,"city":38,"state":7,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Division of Infectious Diseases and Hospital Epidemiology","RECRUITING","Basel","4031","Switzerland","CH",{"type":43,"coordinates":44},"Point",[45,46],7.57327,47.55839,{"lat":46,"lon":45},[49,51],{"name":50,"role":28,"phone":29,"phoneExt":7,"email":30},"Sarah Tschudin Sutter, PD MD",{"name":52,"role":53,"phone":7,"phoneExt":7,"email":7},"Isabelle Vock, Dipl. med.","SUB_INVESTIGATOR",{"type":55,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100370037","epidemiology-of-carbapenemase-producing-bacteria-in-a-swiss-tertiary-care-hospital-100370037",false,"NCT04098133","Epidemiology of Carbapenemase-producing Bacteria in a Swiss Tertiary Care Hospital","CPB-Epi Basel","Inclusion Criteria:\n\n* Patients with detection of carbapenemase-producing bacteria from January 1st , 2008 until December 31st , 2028\n\nExclusion Criteria:\n\n* Patients with documented refusal of subsequent use of their data","ALL","18 Years",{"count":66,"type":67},100,"ESTIMATED","OBSERVATIONAL","This retrospective and prospective study is to investigate the incidence of Carbapenemase-producing bacteria (CPB) at the University Hospital Basel, the time to detection of CPB and to initiation of infection control measures, the risk factors associated with carriage of CPB, type and duration of previously administrated antibiotic medication, antibiotic treatment, as well as to assess the outcomes of the affected patients.",[71],"Infections With CPB",[73,74,75,76],"Carbapenemase-producing Klebsiella pneumoniae","antibiotic resistancy","infections with Carbapenemase-producing Bacteria (CPB)","Carbapenemase-producing Bacteria","2026-06-04",{"date":79,"type":80},"2026-06-08","ACTUAL",{"date":82,"type":80},"2019-08-22",{"date":84,"type":67},"2029-06-30",{"name":5,"class":6},1]